GleamWall
中文EN

GH Guardant Health, Inc.

Services-Medical Laboratories · Nasdaq · SEC CIK 1576280 · Fiscal year ends 12/31

Financial factors as of 2024-12-31 (2024Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY31.0%
TTM net income YoY9.0%
TTM EPS YoY16.8%
Revenue 3-yr CAGR25.5%
Net income 3-yr CAGR—

Margins

Gross margin60.8%
Operating margin-60.0%
Net margin-59.0%
FCF margin-37.2%
EBITDA margin-54.4%

Returns

ROE-4,584.5%
ROA-26.7%
ROIC (approx.)—
Asset turnover0.45x

Leverage & solvency

Liabilities / assets109.4%
Debt / equity—
Current ratio4.68x
Interest coverage-171.87x

Cash quality & payout

Operating cash flow / net income0.55x
Accruals ratio-12.0%
Payout ratio—
Capex / revenue4.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$360.98M$334.98M$301.67M$281.27M$265.20M$232.09M$203.47M$201.81M
Cost of revenue$124.82M$115.95M$104.92M$99.49M$93.59M$81.20M$74.72M$77.59M
Gross profit$236.15M$219.03M$196.75M$181.77M$171.61M$150.88M$128.75M$124.22M
R&D expense$100.84M$96.53M$91.04M$98.26M$89.96M$87.45M$88.52M$93.54M
SG&A expense$90.86M$61.66M$57.93M$60.93M$53.27M$50.26M$46.95M$51.88M
Operating income-$132.76M-$129.12M-$121.35M-$120.81M-$98.99M-$106.41M-$111.04M-$125.97M
Interest expense$1.34M$1.35M$1.35M$1.18M$943,000$983,000$791,000$645,000
Pretax income-$124.02M-$119.96M-$111.70M-$130.22M-$92.59M-$99.86M-$94.87M-$110.29M
Income tax$343,000$185,000$372,000-$1.73M$136,000$38,000$290,000$716,000
Net income-$124.36M-$120.14M-$112.08M-$128.49M-$92.72M-$99.90M-$95.16M-$111.01M
EBITDA-$122.86M-$119.82M-$111.91M-$110.75M-$89.99M-$96.81M-$100.81M-$115.51M
EPS (basic)-0.93-0.90-0.85—-0.74-0.80-0.77—
EPS (diluted)-0.93-0.90-0.85—-0.74-0.80-0.77—
Weighted avg. shares (diluted)134.42M132.87M131.27M—124.81M124.11M123.87M—
Balance sheet
Cash & equivalents$1.03B$1.05B$989.29M$378.20M$580.01M$629.14M$698.57M$629.75M
Short-term investments$0$0$113.47M$823.39M$0$0$0$314.44M
Receivables$186.55M$144.25M$137.40M$137.85M$115.58M$130.25M$115.43M$110.25M
Inventory$93.49M$105.46M$83.85M$85.88M$90.49M$84.06M$77.26M$71.08M
Current assets$1.34B$1.36B$1.37B$1.47B$828.88M$883.43M$927.03M$1.06B
PP&E, net$151.47M$155.30M$150.03M$145.91M$124.61M$126.14M$129.29M$136.81M
Goodwill$77.26M$77.26M$77.26M$77.26M$3.29M$3.29M$3.29M$3.29M
Intangibles$24.99M$25.27M$25.54M$25.92M$5.48M$5.86M$6.28M$6.76M
Total assets$1.89B$1.91B$1.92B$2.01B$1.28B$1.33B$1.34B$1.49B
Current liabilities$373.17M$338.96M$292.14M$302.73M$236.92M$238.43M$225.75M$225.58M
Long-term debt$1.50B$1.50B$1.50B$1.50B$1.11B$1.12B$1.12B$1.14B
Total debt$1.50B$1.50B$1.50B$1.50B$1.11B$1.12B$1.12B$1.14B
Total liabilities$2.16B$2.14B$2.10B$2.11B$1.63B$1.64B$1.60B$1.63B
Shareholders' equity-$275.90M-$222.87M-$181.07M-$99.31M-$354.47M-$305.48M-$250.79M-$139.65M
Net debt$475.56M$449.47M$514.18M$1.13B$534.58M$486.38M$417.77M$512.79M
Shares outstanding134.72M133.61M131.51M130.64M125.01M124.48M123.65M123.99M
Cash flow statement
Operating cash flow-$23.71M-$57.78M-$65.62M-$26.37M-$35.41M-$60.28M-$62.69M-$64.51M
Capital expenditure$13.48M$11.76M$5.58M$27.85M$10.35M$5.65M$4.46M$18.88M
Free cash flow-$37.19M-$69.54M-$71.20M-$54.22M-$45.76M-$65.93M-$67.15M-$83.39M
Investing cash flow-$13.48M$101.47M$699.42M-$905.07M-$14.35M-$10.65M$302.86M$10.53M
Financing cash flow$15.01M$23.01M-$21.58M$732.03M$4.33M$1.62M-$66.85M-$2.94M
Depreciation & amortization$9.90M$9.30M$9.44M$10.05M$9.00M$9.60M$10.24M$10.45M
Stock-based compensation$62.44M$57.73M$47.61M$43.19M$42.81M$42.46M$37.76M$36.37M
Share buybacks$0$0$0$0$0$0$45.01M$0

Free plan shows the latest 8 periods; Pro shows all 37 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.